Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Northampton Chronicle & Echo on MSN
‘By the time he arrived it was too late’ – rare disease expert says '48-hour window of opportunity' missed in Northampton man Luke Abrahams’ death
A rare disease expert told the inquest into Luke Abrahams’ death that ‘there was a 48-hour window where earlier treatment ...
Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...
Apollo Hospitals, Chennai continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported ...
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.
Higher levels of the enzyme PRDX2 reduced damage to lung blood vessels in chronic thromboembolic pulmonary hypertension in a ...
In pulmonary hypertension, the blood vessels in the lungs become narrowed, stiff or blocked, causing pressure to rise inside ...
All of us have what was given to us by nature, how we’ve been created or built. This is how I’ve been created and built,” ...
A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.
Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...
Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.
Penn Highlands Mon Valley continues to provide the latest advancements in heart care. Adil Waheed, DO, FSCAI, a five-board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback